The effect of bisphosphonate medication on orthodontics and orthognathic surgery in patients with osteogenesis imperfecta
Introduction: Osteogenesis imperfecta (OI) is a genetic disease that primarily affects bone formation and metabolism. Craniofacial malfortions belong to the broad spectrum of the OI phenotype. The introduction of bisphosphonate medications was intended to counteract the significant brittleness of th...
Main Authors: | Friedrich, Reinhard E., Scheuer, Hanna A., Höltje, Wolf |
---|---|
Format: | Article |
Language: | deu |
Published: |
German Medical Science GMS Publishing House
2019-03-01
|
Series: | GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW |
Subjects: | |
Online Access: | http://www.egms.de/static/en/journals/iprs/2019-8/iprs000132.shtml |
Similar Items
-
BISPHOSPHONATE THERAPY IN PEDIATRIC PATIENTS WITH OSTEOGENESIS IMPERFECTA
by: Alina Murgu, et al.
Published: (2015-06-01) -
Osteogenesis imperfecta
by: Justin Easow Sam, et al.
Published: (2017-01-01) -
Osteogenesis imperfecta: potential therapeutic approaches
by: Maxime Rousseau, et al.
Published: (2018-08-01) -
Systematic Review on the Incidence of Bisphosphonate Related Osteonecrosis of the Jaw in Children Diagnosed with Osteogenesis Imperfecta
by: Anusha Adeline Hennedige, et al.
Published: (2014-01-01) -
Quality of Life Evaluation in Children With Osteogenesis Imperfecta After Giving Bisphosphonate Infusion in Dr. Soetomo Hospital Surabaya
by: Baskoro Kusumo Riswanto, et al.
Published: (2020-02-01)